The use of prescription opioid medication by patients with borderline personality disorder and axis ii comparison subjects: A 10-year follow-up study

Journal of Clinical Psychiatry

Volumn 75, Issue 4, 2014, Pages 357-361

  Frankenburg, Frances R ^a,b   Fitzmaurice, Garrett M ^a,c   Zanarini, Mary C ^a,c  

^a MCLEAN HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; BACKACHE; BORDERLINE STATE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ABUSE; DRUG USE; DSM-III-R; FAMILY HISTORY; FEMALE; FIBROMYALGIA; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NOCICEPTION; OSTEOARTHRITIS; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL STATUS; SUBSTANCE ABUSE;

ADULT; ANALGESICS, OPIOID; BACK PAIN; BORDERLINE PERSONALITY DISORDER; FEMALE; FIBROMYALGIA; FOLLOW-UP STUDIES; HUMANS; MALE; OSTEOARTHRITIS; PRESCRIPTION DRUGS;

EID: 84899744059     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08557     Document Type: Article

References (38)

1. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non malignant pain: Report of38 cases. Pain. 1986;25(2):171-186.
2. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by US primary care physicians from 1992 to 2001. 1 Pain. 2006;7(4):225-235.
3. Centers for Disease Control and Prevention (CDC). Vital signs: Overdoses of prescription opioid pain relievers United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487-1492.
4. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: A review of the evidence. din I Pain. 2008;24(6):469-478.
5. Compton P, Charuvastra VC, Ling W Pain intolerance in opioid maintained former opiate addicts: Effect of long acting maintenance agent. Drug Alcohol Depend. 2001;63(2):139-146.
6. Doverty M, White JM, Somogyi AA, et al. Hyperalgesic responses in methadone maintenance patients. Pain. 2001;90(1-2):91-96.
7. Fishbain DA, Cole B, Lewis J, et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse! addiction and!or aberrant drug related behaviors? a structured evidence based review. Pain Med. 2008;9(4):444-459.
8. Dodrill CL, Helmer DA, Kosten TR. Prescription pain medication dependence. Am I Psychiatry. 201-1;168(5):466-471.
9. Sansone PA, Sansone LA. Borderline personality and the pain paradox. Psychiatry EdgmonO. 2007;4(4):40
10. Sansone PA, Sansone LA. Chronic pain syndromes and borderline personality. Innov din Neurosci. 2012;9(1):10
11. Zanarini MC, Frankenburg FR, Dubo ED, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatry. 1998;155(12):1733-1739.
12. Zanarini MC, Frankenburg FR, Reich DB, et al. The subsyndromal phenomenology of borderline personality disorder: A 10 year follow up study. Am JPsychiatry. 2007;164(6):929-935.
13. Zanarini MC, Frankenburg FR, Hennen J, et al. The longitudinal course of borderline psychopathology: 6 year prospective follow up of the phenomenology of borderline personality disorder. Am I Psychiatry. 2003;160(2):274-283.
14. Spitzer ilL, Williams JB, Gibbon M, et al. The Structured Clinical Interview for DSM III R (SCID), 1: History, rationale, and description. Arch Gen Psychiatry. 1992;49(8):624-629.
15. Zanarini MC, Gunderson JG, Frankenburg FR, et al. The Revised Diagnostic Interview for Borderlines: Discriminating BPD from other Axis II disorders. JPersDisord. 1989;3(1):10
16. Zanarini MC, Frankenburg FR, Chauncey DL, et al. The Diagnostic Interview for Personality Disorders: Interrater and test retest reliability. Compr Psychiatry. 1987;28(6):467-480.
17. Zanarini MC, Frankenburg FR. Attainment and maintenance of reliability of Axis land II disorders over the course of a longitudinal study. Compr Psychiatry. 2001;42(5):369-374.
18. Zanarini MC, Frankenburg FR, Vujanovic AA. Inter rater and test retest reliability of the Revised Diagnostic Interview for Borderlines. I Pers Disord. 2002;16(3):270-276.
19. Zanarini MC, Frankenburg FR, Yong L, et al. Borderline psychopathology in the first degree relatives of borderline and Axis II comparison probands. I Pers Disord. 2004;18(5):439-447.
20. Frankenburg FR, Zanarini MC. The association between borderline personality disorder and chronic medical illnesses, poor health related lifestyle choices, and costly forms of health care utilization. I din Psychiatry. 2004;65(12):1660-1665.
21. Zanarini MC, Barison LK, Frankenburg FR, et al. Family history study of the familial coaggregation of borderline personality disorder with Axis land nonborderline dramatic cluster Axis II disorders. JPers Disord. 2009;23(4):357-369.
22. Hollingshead AB. Two Factor Index of Social Position. New Haven, CT: Yale University; 1957.
23. Endicott J, Spitzer RI., Fleiss JL, et al. The Global Assessment scale: A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33(6):766-771.
24. Gore M, Tai KS, Sadosky A, et al. Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community based settings. Pain Pract. 2012;12(7):550-560.
25. Hudson JI, Goldenberg DL, Pope HG Jr, et al. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am I Med. 1992;92(4):363-367.
26. Zanarini MC, Gunderson JG, Frankenburg FR. Axis I phenomenology of borderline personality disorder. Compr Psychiatry. 1989;30(2): 149-156.
27. Zimmerman M, Mattia JI. Axis I diagnostic comorbidity and borderline personality disorder. Compr Psychiatry. 1999;40(4):245-252.
28. Fava M. Somatic symptoms, depression, and antidepressant treatment. I din Psychiatry. 2002;63(4):305-307.
29. Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: A review. J din Pharmacol. 2012;52(1):6
30. Harris RE, Clauw DJ, Scott DJ, et al. Decreased central mu opioid receptor availability in fibromyalgia. I Neurosci. 2007;27(37): 10000-10006.
31. Fitzcharles MA, Ste Marie PA, Gamsa A, et al. Opioid use, misuse, and abuse in patients labeled as fibromyalgia. Am JMed. 2011;124(10):955-960.
32. Power C, Frank J, Hertzman C, et al. Predictors of low back pain onset in a prospective British study. Am I Public Health. 2001;9-1(10): 1671-1678.
33. Zanarini MC, Frankenburg FR, DeLuca CJ, et al. The pain of being borderline: Dysphoric states specific to borderline personality disorder. Harv Rev Psychiatry. 1998;6(4):201-207.
34. Martin JE, Inglis J. Pain tolerance and narcotic addiction. BrJ Soc din Psychol. 1965;4(3):224-229.
35. Eisenberger NI, Lieberman MD. Why rejection hurts: A common neural alarm system for physical and social pain. Trends dogn Sci. 2004;8(7):294-300.
36. Stanley B, Siever U. The interpersonal dimension of borderline personality disorder: Toward a neuropeptide model. Am I Psychiatry. 2010;167(1):24
37. Schmahl C, Meinzer M, Zeuch A, et al. Pain sensitivity is reduced in borderline personality disorder, but not in posttraumatic stress disorder and bulimia nervosa. World .1 Biol Psychiatry. 2010;11(2, pt 2):364-371.
38. Streltzer J, Ziegler P, Johnson B; American Academy of Addiction Psychiatry. Cautionary guidelines for the use of opioids in chronic pain. Am I Addict. 2009;18(1):1-4.